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In our discussion of the role of tyrosine kinase networks in the above Preview, we inadvertently omitted an important contribution by
Roger Daly and colleagues (Hochgra¨fe et al., 2010). In this report, the authors demonstrate that there is an enrichment of tyrosine
phosphorylation of Src family and receptor tyrosine kinases in triple-negative breast cancer cell lines and show that inhibition
of multiple tyrosine kinases is an effective strategy against these cancers. These findings presage and complement the finding by
Westbrook and colleagues that PTPN12 loss in triple-negative breast cancers results in activation of tyrosine kinase networks
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